These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 9493701)
1. Barnidipine, a novel calcium antagonist for once-daily treatment of hypertension: a multicenter, double-blind, placebo-controlled, dose-ranging study. Dutch Barnidipine Multicenter Study Group. Hart W; Holwerda NJ Cardiovasc Drugs Ther; 1997 Nov; 11(5):637-43. PubMed ID: 9493701 [TBL] [Abstract][Full Text] [Related]
2. Efficacy and tolerability of once-daily barnidipine in the clinical management of patients with mild to moderate essential hypertension. Spieker C Blood Press Suppl; 1998; 1():15-21. PubMed ID: 9660522 [TBL] [Abstract][Full Text] [Related]
3. The long-term efficacy and safety profile of barnidipine. Smilde JG Int J Clin Pract Suppl; 2000 Nov; (114):20-6. PubMed ID: 11221291 [TBL] [Abstract][Full Text] [Related]
4. Treatment of hypertension in the very old. Otterstad JE; Ruilope LM Int J Clin Pract Suppl; 2000 Nov; (114):10-9. PubMed ID: 11221289 [TBL] [Abstract][Full Text] [Related]
5. Replacement of Amlodipine and Lercanidipine by Barnidipine: Tolerability and Effectiveness in a Real-Life Study. Lins R; Haerden Y; de Vries C High Blood Press Cardiovasc Prev; 2017 Mar; 24(1):29-36. PubMed ID: 28058623 [TBL] [Abstract][Full Text] [Related]
6. Distinct vasodilation, without reflex neurohormonal activation, induced by barnidipine in hypertensive patients. Argenziano L; Izzo R; Iovino G; De Luca N; Parrella L; Morisco C; Trimarco B Blood Press Suppl; 1998; 1():9-14. PubMed ID: 9660521 [TBL] [Abstract][Full Text] [Related]
7. An open-label, randomized, controlled, 4-week comparative clinical trial of barnidipine hydrochloride, a calcium-channel blocker, and benazepril, an angiotensin-converting enzyme inhibitor, in Chinese patients with renal parenchymal hypertension. Chen X; Zheng F; Chen P; Tang L; Wei R; Yu Y; Su Y; Kikkawa T; Yamamoto M J Int Med Res; 2006; 34(2):121-8. PubMed ID: 16749407 [TBL] [Abstract][Full Text] [Related]
8. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension. Philipp T; Smith TR; Glazer R; Wernsing M; Yen J; Jin J; Schneider H; Pospiech R Clin Ther; 2007 Apr; 29(4):563-80. PubMed ID: 17617280 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of the antihypertensive effect of barnidipine, a dihydropyridine calcium entry blocker, as determined by the ambulatory blood pressure level averaged for 24 h, daytime, and nighttime. Barnidipine Study Group. Imai Y; Abe K; Nishiyama A; Sekino M; Yoshinaga K Am J Hypertens; 1997 Dec; 10(12 Pt 1):1415-9. PubMed ID: 9443779 [TBL] [Abstract][Full Text] [Related]
10. Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: a multicenter, randomized, double-blind, 24-week study. Luque Otero M; Martell Claros N; Clin Ther; 2005 Feb; 27(2):166-73. PubMed ID: 15811479 [TBL] [Abstract][Full Text] [Related]
11. Comparative study of barnidipine and felodipine in Chinese patients with essential hypertension. Zhu W; Li T; Ni C; Liu H; Fang L; Shang M; Kikkawa T; Katoh H; Yamamoto M J Int Med Res; 2006; 34(4):406-12. PubMed ID: 16989497 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of barnidipine compared with felodipine in the treatment of hypertension in Chinese patients. Liau CS; Chien KL; Chao CL; Lee TM J Int Med Res; 2002; 30(3):330-6. PubMed ID: 12166353 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and tolerability of nisoldipine coat-core formulation in the treatment of essential hypertension: The South African Multicenter ANCHOR Study. Ambulatory Nisoldipine Coat-Core Hypertension Outpatient Response (ANCHOR) Investigators. Opie LH; Müller FO; Myburgh DP; Rosendorff C; Sareli P; Seedat YK; Weich DJ; Luus HG Am J Hypertens; 1997 Mar; 10(3):250-60. PubMed ID: 9056681 [TBL] [Abstract][Full Text] [Related]
14. Barnidipine compared to lercanidipine in addition to losartan on endothelial damage and oxidative stress parameters in patients with hypertension and type 2 diabetes mellitus. Derosa G; Mugellini A; Pesce RM; D'Angelo A; Maffioli P BMC Cardiovasc Disord; 2016 Apr; 16():66. PubMed ID: 27068332 [TBL] [Abstract][Full Text] [Related]
15. Diversity and intensity of adverse events in the treatment of hypertension with barnidipine. van der Velden JW; Beudeker HJ; Nishi M Blood Press Suppl; 1998; 1():27-9. PubMed ID: 9660524 [TBL] [Abstract][Full Text] [Related]
16. Effects of nilvadipine and amlodipine in patients with mild to moderate essential hypertension: a double blind, prospective, randomised clinical trial. Leonetti G; Curr Med Res Opin; 2005 Jun; 21(6):951-8. PubMed ID: 15969895 [TBL] [Abstract][Full Text] [Related]
17. Effectiveness of barnidipine 10 or 20 mg plus losartan 50-mg combination versus losartan 100-mg monotherapy in patients with essential hypertension not controlled by losartan 50-mg monotherapy: A 12-week, multicenter, randomized, open-label, parallel-group study. Parati G; Giglio A; Lonati L; Destro M; Ricci AR; Cagnoni F; Pini C; Venco A; Maresca AM; Monza M; Grandi AM; Omboni S Clin Ther; 2010 Jul; 32(7):1270-84. PubMed ID: 20678675 [TBL] [Abstract][Full Text] [Related]
18. Nilvadipine in hypertension--experience in ambulatory treatment. Hoffmann A; Kraul H; Burkardt I Int J Clin Pharmacol Ther; 1997 May; 35(5):195-203. PubMed ID: 9174874 [TBL] [Abstract][Full Text] [Related]
19. Barnidipine monotherapy and combination therapy in older patients with essential hypertension: a long-term study. Naber FB; Häge R; Mortelmans J Int J Clin Pract Suppl; 2000 Nov; (114):27-35. PubMed ID: 11221292 [TBL] [Abstract][Full Text] [Related]
20. Comparative study of lacidipine and nifedipine SR in the treatment of hypertension: an Italian multicenter study. The Northern Italian Study Group of Lacidipine in Hypertension. Leonetti G J Cardiovasc Pharmacol; 1991; 17 Suppl 4():S31-4. PubMed ID: 1726003 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]